REMODULIN

Serial Number 76173227
Registration 2618835
800

Registration Progress

Application Filed
Nov 30, 2000
Under Examination
Apr 2, 2002
Approved for Publication
Dec 19, 2001
Published for Opposition
Jan 8, 2002
Registered
Sep 10, 2002

Basic Information

Serial Number
76173227
Registration Number
2618835
Filing Date
November 30, 2000
Registration Date
September 10, 2002
Published for Opposition
January 8, 2002
Renewal Date
September 10, 2022
Drawing Code
1000

Status Summary

Current Status
Active
Status Code
800
Status Date
Jan 14, 2023
Registration
Registered
Classes
005

Rights Holder

United Therapeutics Corporation

03
Address
1110 Spring Street
Silver Spring, MD 20910

Ownership History

United Therapeutics Corporation

Original Applicant
03
Silver Spring, MD

United Therapeutics Corporation

Owner at Publication
03
Silver Spring, MD

United Therapeutics Corporation

Original Registrant
03
Silver Spring, MD

Legal Representation

Attorney
Norm J. Rich

USPTO Deadlines

Next Deadline
2620 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2002-09-10)
Due Date
September 10, 2032
Grace Period Ends
March 10, 2033

Application History

33 events
Date Code Type Description
Jan 14, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 14, 2023 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 14, 2023 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Jan 14, 2023 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jun 29, 2022 E89R I TEAS SECTION 8 & 9 RECEIVED
Sep 10, 2021 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 19, 2012 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 18, 2012 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 18, 2012 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 18, 2012 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 6, 2012 E89R I TEAS SECTION 8 & 9 RECEIVED
Sep 13, 2008 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 4, 2008 PLGL A ASSIGNED TO PARALEGAL
Aug 27, 2008 E815 I TEAS SECTION 8 & 15 RECEIVED
Dec 4, 2007 CFIT O CASE FILE IN TICRS
Sep 10, 2002 R.PR A REGISTERED-PRINCIPAL REGISTER
Jun 24, 2002 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 17, 2002 DOCK D ASSIGNED TO EXAMINER
Jun 14, 2002 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jun 4, 2002 IUAF S USE AMENDMENT FILED
Apr 2, 2002 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 8, 2002 PUBO A PUBLISHED FOR OPPOSITION
Dec 19, 2001 NPUB O NOTICE OF PUBLICATION
Oct 2, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2001 CNEA O EXAMINERS AMENDMENT MAILED
Sep 14, 2001 CNSL S LETTER OF SUSPENSION MAILED
May 9, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2001 CNRT F NON-FINAL ACTION MAILED
Apr 23, 2001 DOCK D ASSIGNED TO EXAMINER
Apr 8, 2001 DOCK D ASSIGNED TO EXAMINER
Apr 5, 2001 DOCK D ASSIGNED TO EXAMINER
Apr 5, 2001 DOCK D ASSIGNED TO EXAMINER
Mar 29, 2001 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
pharmaceutical preparation used in the treatment of cardiovascular, pulmonary, and vascular diseases; A pharmaceutical preparation used in the treatment of cardiopulmonary and cardiovascular diseases
First Use Anywhere: May 21, 2002
First Use in Commerce: May 21, 2002

Classification

International Classes
005